Ivabradine in the treatment of heart failure and coronary artery disease

被引：0
|
作者：
Verschuren, J. J. W. [1 ]
Jukema, J. W. [1 ]
机构：
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
NETHERLANDS HEART JOURNAL | 2011年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：20 / 22
页数：3
相关论文
共 50 条
  • [41] Ivabradine: Current and Future Treatment of Heart Failure
    Thorup, Lene
    Simonsen, Ulf
    Grimm, Daniela
    Hedegaard, Elise R.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2017, 121 (02) : 89 - 97
  • [42] Coronary artery disease management with ivabradine in clinical practice
    Pinto, Fausto J.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2011, 13 (0C) : C25 - C29
  • [43] Arrhythmic effects of Ivabradine in patients with coronary artery disease
    Murat, Sani N.
    Orcan, Salih
    Akdemir, Ramazan
    Dogan, Mehmet
    Kara, Emel
    Balci, Mustafa
    CLINICAL AND INVESTIGATIVE MEDICINE, 2009, 32 (05): : E322 - E326
  • [44] Acute Heart Failure Syndromes in Patients With Coronary Artery Disease Early Assessment and Treatment
    Flaherty, James D.
    Bax, Jeroen J.
    De Luca, Leonardo
    Rossi, Joseph S.
    Davidson, Charles J.
    Filippatos, Gerasimos
    Liu, Peter P.
    Konstam, Marvin A.
    Greenberg, Barry
    Mehra, Mandeep R.
    Breithardt, Guenter
    Pang, Peter S.
    Young, James B.
    Fonarow, Gregg C.
    Bonow, Robert O.
    Gheorghiade, Mihai
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (03) : 254 - 263
  • [45] New insights into coronary artery disease: role of ivabradine
    Steg, Philippe Gabriel
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2010, 12 (0C) : C11 - C15
  • [46] Platelet reactivity in patients with coronary artery disease on treatment with ivabradine and clopidogrel: The PLATIVA study
    Ruiz Pizarro, Virginia
    Vivas, David
    Bernardo, Esther
    Ortega, Aranzazu
    Sanchez Enrique, Cristina
    Enriquez, Daniel
    Palacios Rubio, Julian
    Vilacosta, Isidre
    Fernandez Ortiz, Antonio
    Macaya, Carlos
    DRUGS & THERAPY PERSPECTIVES, 2021, 37 (05) : 222 - 227
  • [47] Treatment: special conditions Co-existing heart disease: coronary artery disease, myocardial infarction, heart failure
    Rosendorff, Clive
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2015, 9 (08) : 651 - 654
  • [48] Ivabradine in Heart Failure The Representativeness of SHIFT (Systolic Heart Failure Treatment With the IF Inhibitor Ivabradine Trial) in a Broad Population of Patients With Chronic Heart Failure
    Das, Debraj
    Savarese, Gianluigi
    Dahlstrom, Ulf
    Fu, Michael
    Howlett, Jonathan
    Ezekowitz, Justin A.
    Lund, Lars H.
    CIRCULATION-HEART FAILURE, 2017, 10 (09)
  • [49] Platelet reactivity in patients with coronary artery disease on treatment with ivabradine and clopidogrel: The PLATIVA study
    Virginia Ruiz Pizarro
    David Vivas
    Esther Bernardo
    Aránzazu Ortega
    Cristina Sánchez Enrique
    Daniel Enríquez
    Julián Palacios Rubio
    Isidre Vilacosta
    Antonio Fernández Ortiz
    Carlos Macaya
    Drugs & Therapy Perspectives, 2021, 37 : 222 - 227
  • [50] Selective If-channel inhibitor ivabradine in the treatment of sinus tachycardia in coronary heart disease patients with acute heart failure and inferior myocardial infarction
    Sayganov, S. A.
    Grishkin, Yu. N.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2010, 9 (03): : 52 - 56
12345